Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Walgreens plans no further wage hikes for pharmacists as shortage eases

Published 03/28/2023, 07:12 AM
Updated 03/28/2023, 12:26 PM
© Reuters. FILE PHOTO: Signage is seen outside of a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly

By Khushi Mandowara and Leroy Leo

(Reuters) - Walgreens Boots Alliance (NASDAQ:WBA) Inc said on Tuesday it does not plan to increase wages further, as a shortage of pharmacists eases after the company doubled down on hiring and pay raises last year.

A labor shortage during the pandemic prompted Walgreens and other U.S. drugstore operators, including CVS Health Corp (NYSE:CVS) and Walmart (NYSE:WMT) Inc, to raise minimum wages to $15 per hour to attract pharmacists.

Walgreens has also lost market share to its rivals after closing several stores during the pandemic, and is aiming to regain it by the end of fiscal year 2023 by reducing pay gap and increasing automation at fulfillment centers.

"We also made the investment to regaining the pharmacy talent in our stores. And it's working for us," CEO Rosalind Brewer said in an investor call.

The company's U.S. retail pharmacy, its core operation, recorded revenue of $27.6 billion in the second quarter ended February, surpassing analysts' estimates of $26.8 billion, as higher prescription drug prices helped soften the blow from declining COVID-19 vaccinations. Same-store pharmacy sales rose 4.9%.

Shares of the company rose 4.3% to $34.37 in midday trading.

Walgreens, one of the largest U.S. pharmacies, has been looking to expand beyond its core business, with acquisitions of healthcare service operators VillageMD and urgent care provider Summit Health.

© Reuters. FILE PHOTO: Signage is seen outside of a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly

The health segment saw a sharp increase in revenue to $1.6 billion, driven by the deals.

Excluding one-off items, the company reported earnings of $1.16 per share for the quarter, higher than the average analyst estimate of $1.10, according to Refinitiv data.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.